Somatic Mutations and Pathobiology of Schnitzler Syndrome

Overview

About this study

This study will perform whole exome sequencing on patients with Schnitzler syndrome to determine whether subclonal mutation are present.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients must meet the Strasbourg criteria for the diagnosis of Schnitzler syndrome

Exclusion Criteria: 

  • Patients whose symptoms are explained by another condition and/or do not meet the minimal Strasbourg criteria for diagnosis of the syndrome

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

David Dingli, M.D., Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20305078

Mayo Clinic Footer